<DOC>
	<DOCNO>NCT02900014</DOCNO>
	<brief_summary>Cell therapy appear alternative treat bone defect . Scientific advance show animal model human mesenchymal stem cell good candidate support cellular bone regeneration transplantation . However , collection require invasive sample usually bone marrow . A new candidate stem cell able stimulate bone regeneration recently identify nasal cavity , cell call `` ecto-mesenchymal '' cell . These stem cell similar biological characteristic mesenchymal stem cell bone marrow . They exhibit high mitogenic activity hold great potential differentiation osteoblast lineage . Given property ease access within nasal cavity , ecto-mesenchymal stem cell offer new prospect cell therapy target bone involvement . In context , ecto-mesenchymal stem cell represent nasal bone reconstruction interest alternative particular indication cleft . They directly easily accessible child conventional surgical reconstruction . The investigator propose study validate production method stem cell call `` ecto-mesenchymal '' isolate biopsy nasal cavity child cleave lip palate able soon propose cell therapy innovative indication .</brief_summary>
	<brief_title>Validation Production Method Stem Cell Isolated From Nasal Cavity Innovative Cell Therapy Cleft Palate</brief_title>
	<detailed_description />
	<mesh_term>Cleft Palate</mesh_term>
	<criteria>Paediatric patient unilateral cleft lip alveolar ( maxilla ) labiomaxillopalatal , require surgical management reconstruction Children weigh 2 kg Children concomitant pathology might alter bone turnover : osteogenesis imperfecta , kidney failure , chronic inflammatory disease , infection , disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Months</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>